A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease.
about
Rational pharmacological approaches for cognitive dysfunction and depression in Parkinson's diseaseMonoamine reuptake inhibitors in Parkinson's disease.Depression in Parkinson's disease: identification and management.Norepinephrine deficiency in Parkinson's disease: the case for noradrenergic enhancement.Use of antidepressants for depression in patients with Parkinson's disease.
P2860
A non-comparative assessment of tolerability and efficacy of duloxetine in the treatment of depressed patients with Parkinson's disease.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
A non-comparative assessment o ...... ents with Parkinson's disease.
@en
A non-comparative assessment o ...... ents with Parkinson's disease.
@nl
type
label
A non-comparative assessment o ...... ents with Parkinson's disease.
@en
A non-comparative assessment o ...... ents with Parkinson's disease.
@nl
prefLabel
A non-comparative assessment o ...... ents with Parkinson's disease.
@en
A non-comparative assessment o ...... ents with Parkinson's disease.
@nl
P2093
P2860
P50
P1476
A non-comparative assessment o ...... ents with Parkinson's disease.
@en
P2093
Andrea Rossi
Grazia Dell'Agnello
Laura Avanzino
Mariangela Pierantozzi
Mauro Silvestrini
Michele Guadagna
Michele Mancini
Riccardo Spezia
Stefano Ruggieri
P2860
P304
P356
10.1517/14656566.2012.736490
P407
P50
P577
2012-11-01T00:00:00Z